These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 16839199)
1. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. Mielcarek N; Debrie AS; Raze D; Bertout J; Rouanet C; Younes AB; Creusy C; Engle J; Goldman WE; Locht C PLoS Pathog; 2006 Jul; 2(7):e65. PubMed ID: 16839199 [TBL] [Abstract][Full Text] [Related]
2. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998 [TBL] [Abstract][Full Text] [Related]
3. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice. Feunou PF; Kammoun H; Debrie AS; Locht C Vaccine; 2014 Jul; 32(34):4281-8. PubMed ID: 24950361 [TBL] [Abstract][Full Text] [Related]
4. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3. Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898 [TBL] [Abstract][Full Text] [Related]
5. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. Feunou PF; Ismaili J; Debrie AS; Huot L; Hot D; Raze D; Lemoine Y; Locht C Vaccine; 2008 Oct; 26(45):5722-7. PubMed ID: 18762220 [TBL] [Abstract][Full Text] [Related]
6. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route. Li R; Lim A; Alonso S Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832 [TBL] [Abstract][Full Text] [Related]
7. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. Thorstensson R; Trollfors B; Al-Tawil N; Jahnmatz M; Bergström J; Ljungman M; Törner A; Wehlin L; Van Broekhoven A; Bosman F; Debrie AS; Mielcarek N; Locht C PLoS One; 2014; 9(1):e83449. PubMed ID: 24421886 [TBL] [Abstract][Full Text] [Related]
8. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model. Kavanagh H; Noone C; Cahill E; English K; Locht C; Mahon BP Clin Exp Allergy; 2010 Jun; 40(6):933-41. PubMed ID: 20184606 [TBL] [Abstract][Full Text] [Related]
10. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. Kammoun H; Feunou PF; Foligne B; Debrie AS; Raze D; Mielcarek N; Locht C Vaccine; 2012 Aug; 30(40):5864-70. PubMed ID: 22814407 [TBL] [Abstract][Full Text] [Related]
11. Pertussis: Where did we go wrong and what can we do about it? Locht C J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992 [TBL] [Abstract][Full Text] [Related]
12. Protective role of adenylate cyclase in the context of a live pertussis vaccine candidate. Lim A; Ng JK; Locht C; Alonso S Microbes Infect; 2014 Jan; 16(1):51-60. PubMed ID: 24140230 [TBL] [Abstract][Full Text] [Related]
13. Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation. Mielcarek N; Debrie AS; Raze D; Quatannens J; Engle J; Goldman WE; Locht C Vaccine; 2006 Apr; 24 Suppl 2():S2-54-5. PubMed ID: 16823926 [TBL] [Abstract][Full Text] [Related]
15. Attenuated Bordetella pertussis BPZE1 protects against allergic airway inflammation and contact dermatitis in mouse models. Li R; Cheng C; Chong SZ; Lim AR; Goh YF; Locht C; Kemeny DM; Angeli V; Wong WS; Alonso S Allergy; 2012 Oct; 67(10):1250-8. PubMed ID: 22909095 [TBL] [Abstract][Full Text] [Related]
16. Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection. Locht C; Papin JF; Lecher S; Debrie AS; Thalen M; Solovay K; Rubin K; Mielcarek N J Infect Dis; 2017 Jul; 216(1):117-124. PubMed ID: 28535276 [TBL] [Abstract][Full Text] [Related]
17. Protective Activity and Safety of Experimental Acellular Pertussis Vaccines Based on Antigenic Complexes Isolated from Biofilm and Planktonic Cultures of Bordetella pertussis. Zaytsev EM; Britsina MV; Ozeretskovskaya MN; Zaitsev AE Bull Exp Biol Med; 2024 Jul; 177(3):349-352. PubMed ID: 39126548 [TBL] [Abstract][Full Text] [Related]
18. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model. Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393 [TBL] [Abstract][Full Text] [Related]
19. Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection. Suzuki K; Shinzawa N; Ishigaki K; Nakamura K; Abe H; Fukui-Miyazaki A; Ikuta K; Horiguchi Y Microbiol Immunol; 2017 Sep; 61(9):371-379. PubMed ID: 28752940 [TBL] [Abstract][Full Text] [Related]
20. Early Protection against Pertussis Induced by Live Attenuated Debrie AS; Mielcarek N; Lecher S; Roux X; Sirard JC; Locht C J Immunol; 2019 Dec; 203(12):3293-3300. PubMed ID: 31732529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]